AIG
ARQT icon

American International Group’s Arcutis Biotherapeutics ARQT Stock Holding History

American International Group’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,976
Closed -$386K – 207
2024
Q1 		$386K Sell
38,976
-335
-0.9% -$2.5K ﹤0.01% 1784
2023
Q4 		$127K Buy
39,311
+13,651
+53% +$37.1K ﹤0.01% 2421
2023
Q3 		$136K Buy
25,660
+912
+4% +$7.76K ﹤0.01% 2338
2023
Q2 		$236K Buy
24,748
+4,716
+24% +$52.3K ﹤0.01% 2075
2023
Q1 		$220K Buy
20,032
+399
+2% +$5.77K ﹤0.01% 2061
2022
Q4 		$291K Buy
19,633
+233
+1% +$4.07K ﹤0.01% 1917
2022
Q3 		$371K Buy
19,400
+3,006
+18% +$68.1K ﹤0.01% 1766
2022
Q2 		$349K Buy
16,394
+2,661
+19% +$54.6K ﹤0.01% 1826
2022
Q1 		$264K Sell
13,733
-967
-7% -$16.4K ﹤0.01% 2080
2021
Q4 		$305K Sell
14,700
-439
-3% -$8.74K ﹤0.01% 2110
2021
Q3 		$362K Sell
15,139
-360
-2% -$8.21K ﹤0.01% 2059
2021
Q2 		$423 Buy
15,499
+2,028
+15% +$57.1K ﹤0.01% 2030
2021
Q1 		$390 Buy
13,471
+1,433
+12% +$44.7K ﹤0.01% 1965
2020
Q4 		$339 Buy
12,038
+1,228
+11% +$30.1K ﹤0.01% 1983
2020
Q3 		$317K Buy
10,810
+5,013
+86% +$134K ﹤0.01% 1840
2020
Q2 		$175K Sell
5,797
-362
-6% -$10.5K ﹤0.01% 2198
2020
Q1 		$184K Buy
+6,159
New +$165K ﹤0.01% 1946

Other funds holding ARQT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American International Group's ARQT Position: Q2 2024 in Review

American International Group sold out of Arcutis Biotherapeutics (ARQT) in Q2 2024, closing a stake of 38,976 shares — an estimated $386K sold.

American International Group first reported a position in ARQT in Q1 2020 and held it in 17 quarters. The position peaked at $386K in Q1 2024. 186 funds tracked by Wall St. Rank hold ARQT as of Q2 2024.

  • American International Group reported no remaining Arcutis Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 38,976 Arcutis Biotherapeutics shares in Q2 2024, an estimated $386K.
  • American International Group first reported a position in Arcutis Biotherapeutics in Q1 2020 and held it in 17 quarters.
  • American International Group's Arcutis Biotherapeutics position peaked at $386K in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.